# PROHANCE
> **NDA020131** · New Drug Application · Sponsor: BRACCO · Approved 1992-11-16
## Drug
- **FDA Application Number:** NDA020131
- **Application type:** New Drug Application
- **Brand name:** PROHANCE
- **Generic name:** GADOTERIDOL
- **Active ingredients:** GADOTERIDOL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BRACCO
- **Manufacturer:** BRACCO DIAGNOSTICS INC
- **First approval:** 1992-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020131)
---
*AI Analytics · CC0 1.0*